1Zadina JE, Hackler L, Ge LJ, etal. A potent and selective en- dogenous agonist for the mu-opiate receptor[J].Nature, 1997, 386 (6624) :499-502.
2art in-Schild S, Zadina JE, Gerall AA, et al. Localization of endomorphin-2 like immunoreactivity in the rat medulla and spi- nal cord[J].Peptides, 1997, 18(10) :1641-1649.
3Champion HC, Zadina JE, Kastin AJ, et al. The endogenous mu-opioid agonists, endomorphin 1 and 2, have vasodilator ac- tivity in the hindquarters vascular bed of the rat[J].Life Sci, 1997, 61(26):PL 409-415.
4Tonini M, Fiori E, Balestra B, et al. Endomorphin-1 and endo- morphin-2 act irate mu-opioid receptors in myenteric neurons of the guinea-pig small intestine[J]. Naunyn Schmiedebergs Arch Pharmacol, 1998, 358(6) :686-689.
6Dal X, Cui SG, Wang T, et al. Endogenous opioid peptides, endomorphin-1 and-2 and deltorphin I, stimulate angiogenesis in the CAM assay[J]. European Journal of Pharmacology, 2008, 579:269-275.
7Lin X, Chen Q, Xue LY, et al. Endomorphine, endogenous opioid peptides, induce apopt osis in human leukemia HL-60 cells[J]. Can J Physial Pharmacol, 2004, 82(11) :1018-1025.
9Mizoguchi H, Narita M, Oji DE, et al. The mu-opioid receptor gene-dose dependent reduct ions in G-protein activation in the pons/medulla and anti-nociception induced by endomorphins in mu-opioid recept or knockout mice[J]. Neuroseienee, 1999, 94 (1) :203-207.
10Nevo I, Avidor-Reiss T, Levy R, etal. Acute and chronic acti- vation of the mu-oplold recept or with the endogenous ligand en- domorphin differentially regulates adenyIyl cyclase isozymes[J]. Neuropharmacology, 2000, 30(a):364-371.
二级参考文献38
1Stefano G et al. Proc Natl Acad Sci USA, 1993;90:11099
2Giulive C et al. J Biol Chem , 1998;273:11038
3Mebmer UK et al. J Biol Chem, 1996;271:20192
4I.D. Welters A et al. Journal of Neuroinmmunology ,2000; 111:139
5Eisaburo Sueoka et al Biochemical and Biophysical , Research Communication, 1998;252:566
6Maneckjee R et al. Proc Natl Acad Sci USA, 1990;87:3294
7Maneckjee R et al. Proc Natl Acad Sci USA, 1992;89:1169
8Wendy L et al . Cancer Letters ,1999;136:177
9Williams G et al. Cell, 1993;74:777
10Rhoda Maneckjee et al. Cell Growth (Differrentiation, 1994;5:1033
1Matsushita T,Watanabe J,Honda G,et al.Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation:A retrospective analysis of an open-label,multicenter,post-marketing surveillance study cohort[J].Thrombosis Research,2014,133(5):772-781.
2Chandran P,Kavalakatt A,Malarvizhi GL,et al.Epigenetics targeted protein-vorinostat nanomedicine inducing apoptosis in heterogeneous population of primary acute myeloid leukemia cells including refractory and relapsed cases[J].Nanomedicine:Nanotechnology,Biology and Medicine,2014,10(4):721-732.
